![John J. Schembri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John J. Schembri
Corporate Officer/Principal chez
AKERO THERAPEUTICS, INC.
Profil
John J.
Schembri currently works at Akero Therapeutics, Inc., as Senior Vice President & Head-Finance.
Mr. Schembri also formerly worked at Cell Genesys, Inc., as Finance Director & Controller from 2003 to 2006, COR Therapeutics, Inc., as Finance Director & Controller from 1998 to 2002, Telik, Inc., as Finance Director & Controller, The Clorox Co., as Principal, Sirna Therapeutics, Inc., as Vice President & Controller from 2006 to 2007, BiPar Sciences, Inc., as Chief Financial Officer, Global Blood Therapeutics, Inc., as Secretary, Vice President-Finance & Administration, and StemPar Sciences, Inc., as Chief Financial Officer & Vice President.
Mr. Schembri received his undergraduate degree from California Polytechnic State University (San Luis Obispo).
Postes actifs de John J. Schembri
| Sociétés | Poste | Début |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de John J. Schembri
| Sociétés | Poste | Fin |
|---|---|---|
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Comptroller/Controller/Auditor | 17/05/2007 |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Directeur Financier/CFO | 01/01/2006 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Directeur Financier/CFO | 01/01/2002 |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Directeur Financier/CFO | - |
| THE CLOROX COMPANY | Corporate Officer/Principal | - |
Formation de John J. Schembri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
The Clorox Co.
 The Clorox Co. Household/Personal CareConsumer Non-Durables Manufactures and markets cleaning, disinfection, bags, wraps, food & cat litter products | Consumer Non-Durables |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
BiPar Sciences, Inc.
 BiPar Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cancer patients | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
StemPar Sciences, Inc.
 StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services Develops cancer drugs treatments | Health Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
